ORIC-944
ORIC-944 is a potent, orally bioavailable, and selective PRC2 inhibitor designed for prostate cancer research. It demonstrates antitumor activity in both cellular assays and in vivo models, making it a valuable tool for investigating epigenetic mechanisms in oncology.
Product Specifications
CAS Number
2369769-29-7
Product Name Alternative
ORIC944
Field of Research
Epigenetics & Chromatin
Purity
98.08% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.23 mM) ; DMSO:80 mg/mL (175.24 mM)
Smiles
N#CC=1N=C2C (=CN=C (NCC=3C (F) =CC=C4OCCC43) N2C1) C5=CC=C (C=C5C) CN (C) C
Molecular Formula
C26H25FN6O
Molecular Weight
456.52
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Wyb3225-1mgEcoli 1 mg (E. coli)
Recombinant HPV-40 E6 (aa 1-154) Protein
Sign In for Pricing
View Details 
K6744308 1.0 µg DNA
Ctps2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)
Sign In for Pricing
View Details